Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001776985-26-000055
Filing Date
2026-08-04
Accepted
2026-08-04 07:01:36
Documents
5
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 6-K form6-kq22026quarterlyrepo.htm 6-K 14873
2 EX-99.1 bntxq22026ex991quarterlyre.htm EX-99.1 2813882
3 a260407_coverxq2a.jpg GRAPHIC 2756318
4 fsridynmyoja6mda5mdg4zmfky.gif GRAPHIC 118
5 fsridynmyoja6mzkwzmyyzjzkz.gif GRAPHIC 122
  Complete submission text file 0001776985-26-000055.txt   6626879
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190840
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 261235398
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)